Daicel (4202) FY2027 Q1 Earnings Report

Quick View

Executive Summary

Although revenue and profit increased at the operating and ordinary income levels, final profit declined slightly due to a higher tax burden and temporary losses. Revenue increased to ¥1523.8B (+9.4% YoY), Operating Income rose to ¥140.4B (+7.7%), and Ordinary Income grew to ¥145.7B (+18.1%), while Net Income attributable to owners of the parent remained at ¥93.6B (-2.7%). The main driver of higher revenue was substantial growth in High Performance Polymers (+23.9%), while growth in Ordinary Income was supported by increased equity-method investment income and lower non-operating expenses. The decline in final profit was primarily attributable to the higher income tax burden (effective tax rate: 33.9%) and a ¥2.7B loss on disposal of fixed assets.

Factors Affecting Results

【Revenue】Revenue of ¥1523.8B (+9.4%) increased in five of the six segments, with High Performance Polymers, the largest segment, serving as the primary driver of company-wide growth at ¥642.3B (+23.9%). Materials declined slightly to ¥502.9B (-2.3%), while Safety at ¥264.9B (+8.2%), Smart at ¥107.8B (+13.7%), and Life Sciences at ¥49.5B (+15.9%) broadened the growth base with increases approaching double digits.

【Profit and Loss】Operating Income was ¥140.4B (+7.7%), with the 9.2% Operating Income margin reflecting a partial offset to the decline in the gross margin to 27.4% (down 1.3pt from 28.7% in the previous year) through the containment of the SG&A expense ratio at 18.2%. Ordinary Income grew faster than Operating Income, increasing to ¥145.7B (+18.1%), supported by the recognition of ¥8.8B in equity-method investment income and improvements in non-operating items, including a reduction in foreign exchange losses. Net special gains and losses amounted to -¥1.2B, consisting of a ¥1.5B gain on the sale of investment securities and a ¥2.7B loss on disposal of fixed assets, and had a limited impact. However, after deducting income taxes of ¥49.1B (effective tax rate: 33.9%) and Net Income attributable to non-controlling interests of ¥1.9B, Net Income attributable to owners of the parent was ¥93.6B (-2.7%). The results present a dual aspect: revenue and profit growth at the operating and ordinary income levels, but a slight decline in final profit due to the higher tax burden.

Segment Analysis

By segment, High Performance Polymers has grown into the core business, generating Revenue of ¥642.3B (+23.9%) and Operating Income of ¥81.0B (+20.9%), with a 12.6% margin, accounting for approximately 57.7% of company-wide Operating Income of ¥140.4B. Materials recorded lower Revenue of ¥502.9B (-2.3%), but Operating Income increased to ¥42.5B (+2.1%), with profitability improving to an 8.4% margin. In contrast, despite higher Revenue of ¥264.9B (+8.2%), Safety’s Operating Income plunged to ¥3.1B (-80.8%), reducing its margin to 1.2% and making it the only segment company-wide to experience deteriorating profitability. Smart contributed with Operating Income of ¥6.7B (+215.5%, 6.2% margin), while Life Sciences contributed Operating Income of ¥5.0B (+138.8%, 10.1% margin); both achieved higher revenue and profit despite their smaller scale. The results indicate that while the shift toward high-performance materials is progressing, deteriorating profitability in Safety is weighing on the company-wide margin.

Key Financial Indicators

【Profitability】The Operating Income margin was 9.2%, the Ordinary Income margin was 9.6%, and the Net Income margin (based on income attributable to owners of the parent) was 6.1%. The gross margin was 27.4%, down 1.3pt from 28.7% in the previous year.【Cash Flow Quality】Trade receivables declined 2.9% to ¥1138.8B from ¥1173.1B in the previous year, while inventories increased to ¥1869.9B (¥1745.2B in the previous year, +7.2%), accounting for 21.6% of total assets. Inventory growth of +7.2% was slightly below Revenue growth of +9.4%, indicating no excessive buildup, although the absolute level remains substantial.【Investment Efficiency】Quarterly ROE was 2.5%. The Equity Ratio (based on equity attributable to owners of the parent) was 42.5%, and asset turnover efficiency relative to total assets of ¥8652.9B was limited.【Financial Soundness】The current ratio was 199.3% (current assets of ¥4203.4B/current liabilities of ¥2109.4B). Total interest-bearing debt consisted of long-term borrowings of ¥1709.5B, bonds of ¥700B, short-term borrowings of ¥415.7B, and other items, totaling approximately ¥3107.7B. Compared with cash and deposits of ¥730.3B, the company has secured sufficient short-term repayment capacity.

Cash Flow Analysis

Although detailed disclosure of the cash flow statement is limited, movements in working capital and funds can be inferred from changes in the balance sheet. Cash and deposits increased to ¥730.3B (¥688.1B in the previous year, +¥42.2B), indicating that cash generation during the period was maintained. Inventories increased to ¥1869.9B (¥1745.2B in the previous year, +¥124.7B), while trade receivables declined to ¥1138.8B (¥1173.1B in the previous year, -¥34.3B), with the movements in the two items largely offsetting each other. Accounts payable increased to ¥704.4B (¥604.5B in the previous year, +16.5%), and trade payables also expanded, suggesting that overall working capital increased naturally in line with business scale expansion. Property, plant and equipment increased to ¥3392.0B (¥3343.6B in the previous year), confirming continued capital investment, including construction in progress of ¥660.5B.

Earnings Quality

Recurring business activities account for the majority of profit, and dependence on temporary factors is low. Net special gains and losses consisted of a ¥1.5B special gain (gain on sale of investment securities) and a ¥2.7B special loss (loss on disposal of fixed assets), for a net amount of -¥1.2B. This had an impact of less than 1% on Profit Before Tax of ¥144.6B. The net balance between non-operating income of ¥20.9B (including dividends received of ¥3.4B and equity-method investment income of ¥8.8B) and non-operating expenses of ¥15.6B (including interest expense of ¥8.8B and foreign exchange losses of ¥2.1B) boosted Ordinary Income, resulting in Ordinary Income of ¥145.7B exceeding Operating Income of ¥140.4B. After deducting income taxes of ¥49.1B (effective tax rate: 33.9%) and Net Income attributable to non-controlling interests of ¥1.9B from Profit Before Tax of ¥144.6B, Net Income attributable to owners of the parent was ¥93.6B. The approximately 35% gap from Profit Before Tax was primarily attributable to the substantial tax burden. Comprehensive Income was ¥206.2B, substantially exceeding Net Income (¥95.5B for the consolidated group), supported by OCI items including foreign currency translation adjustments of ¥48.4B and valuation differences on available-for-sale securities of ¥61.9B. This gap does not directly reflect the earnings power of the core business, and attention is required because it was significantly affected by external factors such as foreign exchange movements and changes in the market value of held equities.

Earnings Forecast and Guidance

Progress against the full-year company forecast was 25.6% for Revenue (¥1523.8B/¥5950B), 33.0% for Operating Income (¥140.4B/¥425B), 33.9% for Ordinary Income (¥145.7B/¥430B), and 29.3% for Net Income (¥93.6B/¥320B). Revenue was progressing in line with the standard quarterly pace of 25%, while Operating Income, Ordinary Income, and Net Income were all progressing ahead of the standard pace. Operating Income was particularly front-loaded by approximately +8pt. This appears to have resulted from higher revenue and profit in High Performance Polymers and improvements in non-operating items, suggesting the possibility of progress being weighted toward the first half. Neither the earnings forecast nor the dividend forecast was revised on this occasion, and the full-year plan remains unchanged.

Shareholder Returns

The full-year dividend forecast is ¥70 per share, implying a Payout Ratio of approximately 55.9% against the company’s forecast EPS of ¥125.30. Quarterly EPS was ¥36.65 (¥36.29 in the previous year, +1.0%), representing progress of 29.3% against full-year forecast EPS and aligning with progress in Net Income. With an Equity Ratio of 42.5% and a current ratio of 199.3%, the financial foundation remains stable, consistent with the unchanged dividend forecast.

Risk Factors

1. Deterioration in Safety profitability: Despite Revenue growth to ¥264.9B (+8.2%), Operating Income plunged to ¥3.1B (-80.8%), reducing the margin to 1.2%. The segment’s contribution to company-wide Operating Income of ¥140.4B is minimal, making a recovery in profitability a key focus for company-wide earnings.

2. Decline in gross margin: The gross margin was 27.4%, down 1.3pt from 28.7% in the previous year. Depending on trends in raw material and energy costs, further downward pressure on margins could arise even amid continued revenue growth.

3. Inventory buildup: Inventories were ¥1869.9B (¥1745.2B in the previous year, +7.2%), accounting for 21.6% of total assets. If market conditions for high-performance materials fluctuate, the relative risk of inventory write-downs and inventory adjustments is at a comparatively high level.

Industry Benchmark (For Reference; Compiled by the Company)

Profitability and Returns

The Operating Income margin is slightly above the industry median, while the Net Income margin is below the median, indicating somewhat weaker relative efficiency at the final stage of earnings within the industry.

Growth and Capital Efficiency

The Revenue growth rate exceeds the industry median by +2.8pt, placing the company among the industry’s higher-growth performers.

※Source: Compiled by the Company

Key Takeaways from the Results

1. The progress rates for Operating Income and Ordinary Income (33.0%, 33.9%) exceed the standard quarterly rate of 25%. The possibility that progress is weighted toward the first half, primarily due to growth in High Performance Polymers, should be considered when evaluating full-year results.

2. High Performance Polymers has grown into the core business, with Revenue of ¥642.3B (+23.9%) and Operating Income of ¥81.0B (+20.9%), accounting for approximately 57.7% of company-wide Operating Income. This indicates that the center of gravity of the business portfolio is shifting toward high-performance materials.

3. While the Safety segment’s margin has declined to 1.2%, there is an approximately 35% gap between Ordinary Income and Net Income attributable to the tax burden (effective tax rate: 33.9%). Both segment profitability and the tax burden should be monitored as factors affecting fluctuations in final profit.

Theoretical Share Price (Reference Value)

This is a reference range mechanically calculated solely from publicly disclosed data using a residual income model (Ohlson-type model with an explicit five-year fade). It is not a forecast of the market share price or a recommendation of any specific investment action.

Sensitivity: ¥1,409–¥1,489 for Cost of Equity ±1%; ¥1,448–¥1,449 for ω±0.1.

Notes:

• Net assets as of the end of the quarter are used (there is a timing difference relative to the full-year forecast).

(Calculation model: Residual income model / Interest rate reference month: 2026-06 / This figure does not forecast or guarantee the future share price)

---

This report is an earnings analysis document automatically generated by AI based on XBRL earnings release data. It does not recommend investment in any specific security. The industry benchmarks are reference information compiled by the Company based on publicly disclosed earnings data. Investment decisions should be made at your own responsibility, after consulting with a professional advisor as necessary.

---End of Report---

---

AI Financial Analysis

Executive Summary

Daicel delivered a solid FY2027 Q1 operating performance, although growth in profit attributable to owners lagged operating earnings because prior-year non-recurring income was unusually high and the tax burden increased. Revenue rose 9.4% year on year to ¥152.4bn. Operating income increased 7.7% to ¥14.0bn. The operating margin was 9.2%, down approximately 15bp from 9.4% in the prior-year quarter. Gross margin contracted by approximately 125bp to 27.4% from 28.7%, indicating that cost of sales grew faster than revenue. This was partly offset by SG&A expense growth of only 3.2%, materially below the 9.4% sales growth rate, demonstrating favorable operating leverage below the gross-profit line. Ordinary income rose 18.1% to ¥14.6bn, and the ordinary-income margin expanded by about 70bp to 9.6%. Lower non-operating expenses, notably a sharp reduction in foreign-exchange losses, supported the stronger ordinary-income result. Profit attributable to owners decreased 2.7% to ¥9.4bn, despite the improvement in ordinary income. The effective tax rate increased to 34.0% from a lower prior-year level that benefited from tax effects, while prior-year extraordinary income included ¥5.1bn of negative-goodwill gain and other gains. In the current quarter, net extraordinary losses were limited to ¥1.2bn, comprising ¥1.5bn of extraordinary income and ¥2.7bn of fixed-asset disposal losses. Total comprehensive income nevertheless increased 85.3% to ¥206.2bn, supported by favorable securities valuation and foreign-currency translation adjustments. The High Performance Polymers business was the largest operating-profit contributor and led growth, while Safety profitability weakened sharply despite revenue growth. Q1 revenue progress against full-year guidance was 25.6%, broadly in line with the 25% seasonal benchmark. Operating-income progress was stronger at 33.0%, 8.0 percentage points above the standard benchmark, while ordinary-income progress was 33.9%. Profit attributable to owners reached 29.3% of the full-year forecast, also ahead of a straight-line Q1 pace. The balance sheet remains liquid, with a 199.3% current ratio and 110.6% quick ratio, but long working-capital cycles remain a material operational focus. Management maintained its full-year outlook and dividend forecast, implying that the early operating-income outperformance has not yet been translated into a forecast revision.

Profitability Analysis

The reported annualized ROE is 9.8%, derived through the supplied DuPont framework as a 6.1% net profit margin × 0.704x asset turnover × 2.26x financial leverage. Compared with an implied prior-year-quarter annualized ROE of roughly 10.4%, the principal negative movement is the net-margin decline, rather than a change in leverage. The current 6.1% net margin is approximately 77bp below the prior-year level of about 6.9%, reflecting the higher tax burden and the absence of the prior-year negative-goodwill gain. Asset turnover improved from an implied 0.668x to 0.704x on an annualized basis, supported by 9.4% revenue growth exceeding the 3.8% increase in total assets. Financial leverage was broadly stable at 2.26x, versus an implied 2.25x in the prior-year quarter. Gross margin declined to 27.4% from 28.7%, showing pressure within production costs and/or sales mix. However, SG&A increased only 3.2% to ¥27.8bn, against a ¥13.1bn increase in sales, which limited operating-margin compression to approximately 15bp. The 9.2% operating margin remains in the good 8-15% benchmark range for a manufacturer. High Performance Polymers is the core business, generating segment profit of ¥8.1bn, or 57.7% of consolidated operating income, on external sales of ¥64.2bn. Its segment profit increased 20.9% year on year and its segment margin improved to 12.6% from 12.9% on the stated external-sales basis, with strong 23.9% sales growth. Material revenue declined 6.2% to ¥45.7bn, but segment profit increased 2.1% to ¥4.2bn, supporting margin resilience. Safety sales grew 8.2% to ¥26.5bn, but segment profit fell 80.8% to ¥0.3bn and its margin contracted to 1.2% from 6.6%, making this the principal segment-level earnings concern. Smart sales increased 12.4% to ¥10.6bn and segment profit more than tripled to ¥0.7bn, lifting margin to 6.3%. Life Science delivered 15.8% sales growth and 138.8% segment-profit growth, though its ¥0.5bn contribution remains comparatively small. Interest coverage of 15.92x remains strong, and the 1.030 interest-burden factor indicates that non-operating income more than offset net financing costs at the pre-tax level.

Growth Assessment

Revenue growth was broad-based but was led by High Performance Polymers, where sales rose ¥12.4bn year on year. The segment's scale and double-digit profitability make its growth particularly important for consolidated earnings sustainability. Smart and Life Science also expanded at double-digit rates, supporting a more diversified growth profile. Material sales declined ¥3.0bn, indicating that growth was not uniform across the portfolio. Safety revenue growth did not convert into profit growth, suggesting unfavorable mix, cost, pricing, or start-up dynamics within that business; its recovery is important to sustaining group margin expansion. Consolidated gross profit rose 4.6%, below revenue growth, whereas operating income rose 7.7% because SG&A discipline offset much of the gross-margin pressure. Ordinary income outgrew operating income due to lower non-operating expenses, including FX losses of ¥0.2bn compared with ¥1.7bn in the prior-year quarter. This support is less directly recurring than segment-level revenue and gross-profit expansion. Current-quarter operating income represents 33.0% of the ¥42.5bn full-year forecast, exceeding the 25% Q1 benchmark by 8.0 percentage points. Revenue progress of 25.6% is close to the standard seasonal pace against the ¥595.0bn full-year forecast. The disparity between operating-income and revenue progress implies that management's full-year assumptions embed some margin normalization, seasonal cost increases, or a more conservative second-half outlook. No guidance revision was announced, so the Q1 result should be viewed as favorable initial execution rather than confirmation of a full-year upgrade. The annual operating-income forecast calls for only 1.0% growth, materially below the Q1 7.7% increase, increasing the importance of subsequent-quarter demand, input-cost, and Safety-segment trends. There was no reported segment fixed-asset impairment in the quarter, which supports the current carrying value of the operating asset base.

Financial Health

Liquidity is sound. Current assets of ¥420.3bn exceeded current liabilities of ¥210.9bn, producing working capital of ¥209.4bn and a current ratio of 199.3%. The quick ratio was also healthy at 110.6%, meaning liquid assets excluding inventories were sufficient to cover current obligations. Cash and deposits totaled ¥73.0bn, equivalent to 1.76x short-term debt under the reported credit metric. The short-term debt ratio was 19.6%, indicating that debt maturities are predominantly longer dated rather than concentrated in the coming year. Interest-bearing debt was ¥212.5bn and the reported debt-to-equity ratio was 1.26x, a moderate level that is below the 2.0x aggressive-financing threshold. Debt-to-capital of 35.7% is also within the sub-40% investment-grade benchmark. Interest coverage of 15.92x provides substantial headroom for current financing costs. Total equity increased 3.5% year on year to ¥383.3bn, while total assets increased 3.8% to ¥865.3bn, leaving the capital adequacy ratio broadly stable at 42.5%. Noncurrent liabilities of ¥271.0bn exceeded current liabilities, consistent with the predominantly long-term funding profile. Property, plant and equipment represented 39.2% of total assets, reflecting a capital-intensive manufacturing base. Construction in progress increased ¥6.2bn year on year to ¥66.1bn, indicating an active investment pipeline that should be monitored for completion timing and returns. Investment securities increased ¥9.1bn year on year to ¥54.7bn and represent 6.3% of assets; their valuation sensitivity contributed to comprehensive income. Treasury stock decreased in absolute value from ¥15.7bn to ¥1.0bn, a ¥14.7bn reduction, materially increasing the reported equity base; the accounting presentation indicates a major capital-structure movement that investors should track alongside future shareholder-return actions. Goodwill was only ¥0.5bn, or effectively 0.0% of equity and assets, so balance-sheet dependence on acquisition value retention is negligible. Asset retirement obligations were ¥1.2bn, equivalent to approximately 0.3% of total liabilities, indicating a limited recorded environmental-remediation liability burden.

Notable B/S Changes

Treasury stock: increased by ¥147.1bn toward zero (from -¥157.3bn to -¥10.2bn) - a major equity-structure movement that materially affects the reported equity base and should be monitored with shareholder-return disclosures. Investment securities: +¥9.1bn (+20.3%) to ¥54.7bn - higher exposure to market-price movements, consistent with securities valuation gains contributing to comprehensive income. Construction in progress: +¥6.2bn (+10.3%) to ¥66.1bn - indicates an expanding manufacturing investment pipeline; execution timing and project returns warrant monitoring. Inventories: +¥12.5bn (+7.1%) to ¥187.0bn - large working-capital commitment and consistent with the 154-day inventory quality alert. Accounts payable: +¥10.0bn (+16.5%) to ¥70.4bn - supplier financing increased, partly offsetting the cash impact of higher inventories. Accumulated other comprehensive income: +¥10.6bn (+10.5%) to ¥111.4bn - driven by favorable foreign-currency translation and securities valuation movements, increasing equity sensitivity to market variables.

Cash Flow Quality

Cash-flow quality cannot be directly assessed from the available figures because operating cash flow, investing cash flow, financing cash flow, capital expenditure, depreciation, and free cash flow were not reported. Accordingly, no OCF-to-net-income ratio, cash-conversion ratio, accruals ratio, or free-cash-flow coverage calculation is presented. Balance-sheet working-capital indicators nevertheless identify a material cash-conversion risk. Reported receivable days are 68 days, above the 60-day quality-alert threshold and above the 45-day manufacturing efficiency benchmark. The root cause is that trade receivables of ¥113.9bn remain substantial relative to annualized quarterly sales, although the receivable balance fell 2.9% year on year while sales rose 9.4%, which is directionally constructive. The impact is that delayed collections can constrain operating-cash conversion even when reported earnings are growing. Inventory days are 154 days, above both the 90-day warning level and the stricter 60-day manufacturing benchmark. The root cause is inventory of ¥187.0bn, equal to 21.6% of total assets and up 7.1% year on year. For a diversified chemical and materials manufacturer, inventory buffers can reflect complex production cycles, customer-service requirements, and raw-material procurement; however, 154 days remains high and creates exposure to demand changes, price declines, and inventory obsolescence. The impact is potentially significant because inventory is the largest current-asset category and may absorb cash that could otherwise support investment, deleveraging, or distributions. The reported annualized cash conversion cycle is 164 days, above the 120-day quality-alert threshold. This lengthy cycle is driven by the combination of elevated inventory days and slow receivable collection, despite accounts payable increasing 16.5% year on year to ¥70.4bn. Investors should monitor whether future sales growth converts into lower inventory days and faster collections rather than further working-capital investment. Net extraordinary losses were modest at ¥1.2bn, limiting the degree to which Q1 earnings depend on one-time items, but the cash realization of earnings remains unverified without operating-cash-flow data.

Dividend Sustainability

The full-year dividend forecast is ¥70 per share, unchanged from the prior forecast. Against forecast EPS of ¥125.30, the implied forecast dividend payout ratio is approximately 55.9%. This is below the 60% sustainability benchmark and therefore appears supportable on forecast accounting earnings. Q1 EPS was ¥36.65, representing 29.3% of forecast annual EPS, broadly consistent with the Q1 progress rate for profit attributable to owners. The prior-year first-quarter dividend per share was ¥30, but no current-quarter dividend amount is presented. The reduction in treasury stock in the balance sheet is a significant shareholder-capital movement, but the available data do not quantify whether it reflects cancellation, reissuance, or another transaction; therefore, no total return ratio is calculated. Free-cash-flow coverage of dividends cannot be assessed from the available information. The strong liquidity position, moderate reported leverage, and 15.92x interest coverage provide balance-sheet capacity for the indicated dividend. However, the 164-day cash conversion cycle and elevated inventory balance mean that sustainable cash distributions depend on improving working-capital conversion. The unchanged dividend forecast alongside maintained earnings guidance suggests management currently views the planned distribution as compatible with its operating and investment requirements.

Risk Assessment

Business risks include High Performance Polymers accounts for 57.7% of consolidated operating income; its product-demand, automotive/industrial-cycle, customer-concentration, and raw-material-cost exposure therefore have an outsized effect on group earnings., Safety segment profit fell 80.8% year on year to ¥0.3bn despite 8.2% revenue growth, reducing its margin to 1.2%. The likelihood of continued margin volatility is elevated until the cause of the revenue-profit divergence is reversed., Gross margin declined approximately 125bp to 27.4%, exposing the group to chemical feedstock, energy, logistics, and pricing-pressure risks., Chemical manufacturing operations face environmental, safety, quality-control, and regulatory risks. Recorded asset retirement obligations are limited, but operational incidents or regulatory changes can create costs beyond currently recorded obligations., Foreign-exchange losses were ¥0.2bn in Q1, materially below ¥1.7bn in the prior-year quarter. The favorable year-on-year movement in non-operating expenses may not persist if currency conditions reverse..

Financial risks include Receivable days of 68 exceed the 60-day quality-alert threshold. Although receivables declined year on year, slower collection than manufacturing benchmarks may restrain operating cash generation., Inventory days of 154 exceed the 90-day warning threshold and the 60-day manufacturing benchmark. The ¥187.0bn inventory balance creates material cash tie-up and potential valuation risk if demand or input prices weaken., The 164-day cash conversion cycle exceeds the 120-day warning threshold. This indicates that earnings growth may require continued working-capital funding unless inventory and receivable efficiency improve., Interest-bearing debt of ¥212.5bn and D/E of 1.26x are manageable, but debt remains material in absolute terms and should be assessed against future cash generation and capital-investment requirements., Investment securities of ¥54.7bn and accumulated valuation/translation adjustments of ¥111.4bn introduce equity and comprehensive-income sensitivity to market prices and exchange rates..

Key concerns include Highest priority: normalize Safety segment profitability and determine whether its sharp margin decline is temporary or structural., Highest priority: reduce inventory intensity and shorten the cash conversion cycle; inventory is 21.6% of total assets and is the primary working-capital risk., Medium priority: sustain gross-margin recovery while preserving SG&A discipline, since Q1 operating growth relied partly on expense leverage rather than gross-margin expansion., Medium priority: validate that above-seasonal operating-income progress can be retained through the remainder of the fiscal year without reliance on favorable non-operating FX movements., Medium priority: monitor construction in progress of ¥66.1bn for project execution, timing, and return-on-capital discipline..

Investment Implications

Key takeaways include Q1 sales and operating profit grew 9.4% and 7.7%, respectively, with operating income reaching 33.0% of the full-year forecast., High Performance Polymers is the core profit engine, contributing ¥8.1bn of segment profit and delivering 20.9% year-on-year profit growth., SG&A discipline was favorable, but gross-margin compression and the Safety segment's 80.8% profit decline temper the otherwise strong operating result., Annualized ROE of 9.8% is supported by improving asset turnover and stable leverage, but remains below the 10-15% good benchmark because the net margin declined., Liquidity and interest-servicing capacity are strong, while elevated inventory, receivable days, and a 164-day cash conversion cycle are the principal balance-sheet efficiency issues., The ¥70 forecast DPS implies a 55.9% payout ratio on forecast EPS, which is reasonable on earnings but requires confirmation from future cash-flow performance..

Metrics to watch include Safety segment revenue, segment profit, and margin recovery, High Performance Polymers sales growth and segment margin, Gross margin and SG&A-to-sales ratio, Inventory days, receivable days, payable days, and cash conversion cycle, Operating cash flow and free cash flow relative to net income and dividends, Progress against ¥595.0bn revenue, ¥42.5bn operating income, ¥43.0bn ordinary income, and ¥32.0bn profit-attributable guidance, Construction-in-progress conversion into productive assets and returns, FX-related non-operating gains and losses, plus investment-securities valuation movements.

Regarding relative positioning, Daicel shows solid mid-range manufacturing profitability, with a 9.2% operating margin and strong 15.92x interest coverage. Its leverage and liquidity profile are acceptable rather than aggressively financed, and its negligible goodwill limits M&A-related impairment risk. Relative to efficient manufacturing benchmarks, however, 68-day receivables, 154-day inventory, and a 164-day cash conversion cycle indicate materially weaker working-capital efficiency. The earnings profile is therefore strongest where High Performance Polymers growth and cost control continue, but it is less robust where Safety profitability and cash conversion remain unresolved.